Innate Pharma (IPHA) — Strategic Asset Allocation Index
Innate Pharma (IPHA) has a Strategic Asset Allocation Index of 202.0% as of June 2025. Strategic assets (PP&E of $- plus long-term investments of $10.39 Million) total $10.39 Million, measured against net assets of $5.14 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Innate Pharma (IPHA) balance sheet quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Innate Pharma Strategic Asset Allocation Index (2015–2024)
This chart shows how Innate Pharma's Strategic Asset Allocation Index has evolved across 10 annual periods from 2015 to 2024. As of June 2025, the index stands at 202.0%, representing strategic assets of $10.39 Million against net assets of $5.14 Million USD. For live market cap and overall valuation, see Innate Pharma (IPHA) total market value.
Annual Strategic Asset Allocation Index for Innate Pharma (2015–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for Innate Pharma from 2015 to 2024, covering 10 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See what is Innate Pharma's book value for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 116.4% | $10.28 Million | $- | $10.28 Million | $8.83 Million | ▲ +93.5 pp |
| 2023 | 22.8% | $9.80 Million | $- | $9.80 Million | $42.90 Million | ▼ -57.8 pp |
| 2022 | 80.6% | $43.66 Million | $8.54 Million | $35.12 Million | $54.15 Million | ▲ +34.0 pp |
| 2021 | 46.6% | $50.05 Million | $10.17 Million | $39.88 Million | $107.44 Million | ▲ +14.1 pp |
| 2020 | 32.5% | $50.63 Million | $11.69 Million | $38.93 Million | $155.97 Million | ▲ +10.1 pp |
| 2019 | 22.4% | $48.68 Million | $11.67 Million | $37.01 Million | $217.42 Million | ▼ -4.8 pp |
| 2018 | 27.1% | $45.40 Million | $10.22 Million | $35.18 Million | $167.24 Million | ▼ -55.7 pp |
| 2017 | 82.8% | $71.20 Million | $10.73 Million | $60.47 Million | $85.96 Million | ▲ +34.0 pp |
| 2016 | 48.8% | $42.07 Million | $9.09 Million | $32.98 Million | $86.17 Million | ▼ -10.8 pp |
| 2015 | 59.6% | $42.95 Million | $6.85 Million | $36.10 Million | $72.07 Million | — |